New drug approved for treatment of tardive dyskinesia is:
Tardive dyskinesia is late symptom which appears on treatment with typical antipsychotic like haloperidol. It occurs due to D2 receptor supersensitivity. Treatment of choice isvalbenazine Tetrabenazine and deutetrabenazine are use in Huntington's chorea. Safinamide is a new MAO B inhibitor which is use for treatment of Parkinson.
Safinamide
Tetrabenazine
Valbenazine
Deutetrabenazine
JIPMER 2017